In this article, we will discuss: 7 Best Cannabis Stocks to Invest In Now.
Cannabis stocks are ownership stakes in publicly traded businesses engaged in the legal manufacturing, advertising, and distribution of cannabis, marijuana, and hemp-related products.
According to a January 15, 2026, Cannabis Business Times story by David Silverberg, U.S. cannabis operators saw price compression, oversupply, and legislative failures in 2025, which led to margin pressure and a rise in M&A activity. Robert Groesbeck, co-CEO of Planet 13, the world’s largest cannabis dispensary, brought up Florida’s unsuccessful 2024 ballot and Nevada’s declining tourism. LeVar Thomas of Silly Nice mentioned competition and regulatory costs. University of California, Davis professor Robin Goldstein stressed hemp’s growth and questioned the effects of rescheduling. Abacus Data analysis revealed that 35% of Canadian adults smoked cannabis in the previous six months, while Megan McCrae, senior vice president, Corporate Strategy & International Growth of Organigram, the cannabis company, stated that international wholesale revenue almost tripled year over year.
Groesbeck’s notes, growth depends on tax and financial policies being clear and transparent. Goldstein cautioned that interstate trade might lead to price competition. Pre-rolls, vapes, and beverages were predicted to gain popularity by McCrae and George Archos.
With that said, here are the 7 Best Cannabis Stocks to Invest In Now.
Our Methodology
We sifted through the online rankings to form an initial list of the 15 Best Cannabis Stocks to Invest In Now. From the resultant dataset, we chose the 7 Best Cannabis Stocks with the highest number of hedge fund holders for each stock using Insider Monkey’s database of hedge funds as of Q3 2025. We also considered the analysts’ upside potential as of February 10. Finally, we ranked these stocks in ascending order based on hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
7. Organigram Global Inc. (NASDAQ:OGI)
Number of Hedge Fund Holders: 3
Analysts’ Upside Potential as of February 10: 72.59%
Organigram Global Inc. (NASDAQ:OGI) is among the Best Marijuana Stocks.
Organigram Global Inc. (NASDAQ:OGI) reported Q1 revenue of $97.3 million, exceeding the $73.15 million consensus, based on a February 10, 2026, TheFly report. Adjusted EBITDA was $5.3 million, up from $1.4 million in the previous year. The corporation reported higher profits and solid revenue growth over the previous year. Higher flower yields, synergies from the Motif integration, more international sales, and operational efficiency all contributed to the adjusted gross margin’s sustained growth. The company anticipates continued international revenue growth in fiscal 2026.
Canaccord began covering the stock on January 27, 2026, with a C$3 price target and a Buy rating. The corporation stated that despite structural inefficiencies and legal obstacles, the Canadian cannabis market continues to be a global benchmark. Organigram Global Inc. (NASDAQ:OGI), the market leader in pre-rolls, extracts, and milled flower, is speeding up its shift to become a globally integrated, vertically integrated cannabis corporation.
Organigram Global Inc. (NASDAQ:OGI) provides high-quality, indoor-grown cannabis to patients and adult recreational customers. It also seeks international business alliances to expand the company’s global presence.
6. Advanced Flower Capital Inc. (NASDAQ:AFCG)
Number of Hedge Fund Holders: 6
Analysts’ Upside Potential as of February 10: 314.75%
Advanced Flower Capital Inc. (NASDAQ:AFCG) is among the Best Marijuana Stocks.
TheFly on Jan 05, 2026, stated that, as of January 1, 2026, Advanced Flower Capital Inc. (NASDAQ:AFCG) has successfully converted from a real estate investment trust to a business development company according to the Investment Company Act of 1940. The conversion increases long-term shareholder value by broadening the company’s investment options beyond real estate-backed loans to encompass a wider spectrum of operational enterprises.
In the most recent quarter, Advanced Flower Capital Inc. (NASDAQ:AFCG) recorded a GAAP net loss of $12.5 million, or $0.57 per basic weighted average common share. The amount of $3.5 million in distributable earnings, or $0.16 per basic weighted average common share, was reported. The company stated that it is resolving nonaccrual issues and increasing loan repayments, despite seeing limited new funding enter the cannabis market. Proposals about its plan to change from a REIT to a BDC were accepted by shareholders. It is anticipated that the conversion will be finished in the first quarter of 2026, pending regulatory procedures and customary conditions.
Advanced Flower Capital Inc. (NASDAQ:AFCG) offers commercial real estate financing services. Its main operations include developing, arranging, underwriting, and overseeing senior secured loans as well as other loan types for well-established businesses involved in the cannabis industry in several states.
